We are Sorry, This Page doesn't Exist
Lyft gives up debut gains in second day of trading
Shares of ride-hailing company Lyft Inc crashed below their initial public offering price in just their second day of trading on Monday, matching the speed at which Facebook Inc gave up its IPO price after a rocky debut nearly seven years ago......»»
Lyft gives up debut gains on second day of trading
Shares of Lyft Inc crashed .....»»
Stocks rise on last day of blockbuster quarter; Lyft jumps in its debut
U.S. stocks climbed Friday, extending the mar.....»»
US stocks extend gains in early trading; Lyft to debut
Stocks moved broadly higher on Wall Street in early trading Friday, extending gains from a day earlier......»»
Why Marijuana Stock Cronos Group Has Skyrocketed 104% So Far in 2019
The cannabis company is enjoying torrid gains following a blockbuster deal with a tobacco titan......»»
Wall Street jumps as tech roars back, yields retreat
(Reuters) - Facebook's 9.4 percent jump after blockbuster results and gains in chipmakers powered technology stocks on Thursday, with easing U.S. bond yields helping the sentiment on Wall Street......»»
Allergan tops estimates as Botox, aesthetics products drive gains
(Reuters) - Allergan Plc's quarterly profit topped Wall Street forecasts, driven by higher sales of its medical aesthetics products including blockbuster wrinkle treatment Botox......»»
Indostar Capital Finance stocks ends with 2% gains on stock market debut
On NSE, shares of the company settled at Rs 585, a gain of 2.27 per cent.....»»
Xiaomi Dials Up Big Gains on Second Day of Trading
Xiaomi shares soared, as the prospect of rapid inclusion in key indexes helped make up for the Chinese smartphone-maker lackluster market debut a day earlier......»»
Merck profit beats, but Keytruda sales fail to impress
Merck & Co beat quarterly profit estimates on Friday as sales of its blockbuster drug Keytruda overtook rival Bristol-Myers Squibb's Opdivo, but that was not enough for investors who expected bigger gains in market share for the cancer therapy......»»
New Osteoarthritis Treatment Could Precipitate Another Blockbuster Drug
Teva and Regeneron both saw handy gains on Thursday after the companies posted positive topline results from their late-stage trial of fasinumab in patients with chronic pain from osteoarthritis........»»
Arvinas stock pares gains in debut, rise 2.7% above IPO price after being up as much as 33%
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
'Red Dead Redemption 2' rakes in $725M for Rockstar Games in blockbuster weekend debut
Video game "Red Dead Redemption 2" corralled blockbuster sales of $725 million in its first three days, according to publish.....»»
Wall Street rises on gains in retailers as Cyber Monday begins
U.S. stocks gained on Monday, helped by shares of retailers on expectations of blockbuster sales on the largest online shopping day of the year, and as technology shares rose after taking a beating last week......»»
U.S. Stocks Sprint Ahead to End a Blockbuster Week
U.S. stocks rallied Friday afternoon, leaving all three major indexes with weekly gains of about 5%......»»
Market Extra: The last time the S&P 500 had this strong a January surge ‘Fatal Attraction’ was in theaters
The S&P 500 is on pace for its best January in more than three decades. To put that in perspective, gains for the major benchmark haven’t been this heady in January since “Fatal Attraction†made its theatrical debut in 1987......»»
Market Extra: ‘Fatal Attraction’ was in theaters the last time the S&P 500 did this well in January
The S&P 500 is on pace for its best January in more than three decades. To put that in perspective, gains for the major benchmark haven’t been this heady in January since “Fatal Attraction†made its theatrical debut in 1987......»»
Anchiano Therapeutics" stock set to close well below its IPO price
Shares of Anchiano Therapeutics Ltd. was on track to close below its initial public offering price on its debut, bucking the gains in its Nasdaq biotechnology peers and the broader stock market. The stock's first trade was at its IPO price of $11.....»»
Top Memecoins Defy Cryptocurrency Market Downturn: Pepe, Floki, Dogecoin Lead With Impressive Gains
The ongoing downturn in the cryptocurrency market has underscored the strength of the more established memecoins over the several new ones birthed during the memecoin frenzy earlier this year. read more.....»»